In this enlightening session, we will delve into the groundbreaking realms of programmable gene and cell therapies, two of the most promising frontiers in synthetic biology. Our focus will be on the latest advancements in these fields, emphasizing how they are reshaping the landscape of medical treatments for a myriad of diseases, including genetic disorders and cancers. We will explore the intricacies of gene editing techniques, such as CRISPR-Cas9, and their application in developing precise gene therapies that target and modify specific genetic defects. Additionally, the session will cover the evolution and impact of programmable cell therapies, particularly CAR-T cell therapy, which has shown remarkable success in treating certain types of cancer. This session aims to provide a comprehensive understanding of how these innovative therapies work, their potential risks and benefits, and the ethical considerations surrounding their use. By bringing together leading experts and researchers, we aim to foster a scientific dialogue on the challenges and future prospects of these transformative therapeutic modalities in modern medicine.